View in EDS HTML Full Text PDF Full Text

Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.

Saved in:
Bibliographic Details
Title: Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
Authors: Cook MM; Oregon Health & Science University, Portland, Oregon, USA., Al Rabadi L; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA., Kaempf AJ; Knight Cancer Institute Biostatistics Shared Resource, Oregon Health & Science University, Portland, Oregon, USA., Saraceni MM; Department of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA., Savin MA; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA., Mitri ZI; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.
Source: The oncologist [Oncologist] 2021 Feb; Vol. 26 (2), pp. 101-106. Date of Electronic Publication: 2020 Dec 14.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33230905
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cook+MM%22">Cook MM</searchLink>; Oregon Health & Science University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Al+Rabadi+L%22">Al Rabadi L</searchLink>; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Kaempf+AJ%22">Kaempf AJ</searchLink>; Knight Cancer Institute Biostatistics Shared Resource, Oregon Health & Science University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Saraceni+MM%22">Saraceni MM</searchLink>; Department of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Savin+MA%22">Savin MA</searchLink>; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Mitri+ZI%22">Mitri ZI</searchLink>; Department of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2021 Feb; Vol. 26 (2), pp. 101-106. <i>Date of Electronic Publication: </i>2020 Dec 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33230905
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/onco.13609
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101
    Titles:
      – TitleFull: Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cook MM
      – PersonEntity:
          Name:
            NameFull: Al Rabadi L
      – PersonEntity:
          Name:
            NameFull: Kaempf AJ
      – PersonEntity:
          Name:
            NameFull: Saraceni MM
      – PersonEntity:
          Name:
            NameFull: Savin MA
      – PersonEntity:
          Name:
            NameFull: Mitri ZI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2021 Feb
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1